All potential predictive factors including age, pathology, hypertension, diabetes, clinical stage, ER status, PR status, HER-2 status, Ki-67, type of surgery, radiotherapy, adjuvant chemotherapy, endocrine therapy, target therapy, CEA, CA153, NLR, PLR, and HALP were included in Cox regression survival analysis. This evidence concerns the gene PGR and hypertensive disorder.